ALKERMES | Capitale Di Prestito



Loan Capital Cambiamento Data
AbbVie USD 60.34B 1.83B 2024-12
Acadia Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 0 2025-03
Amgen USD 54.01B 2.54B 2025-03
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.65M 244K 2025-03
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
Ionis Pharmaceuticals USD 1.25B 5.23M 2025-03
J&J USD 38.36B 7.7B 2025-03
Malin Corporation EUR 0 0 2024-06
Merck USD 33.48B 978M 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Otsuka Holdings JPY 126.44B 34.45B 2025-03
Pfizer USD 57.64B 234M 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



ALKERMES Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.